These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 436923)

  • 1. Relationship between bronchial effects and plasma practolol concentration in man.
    Oh VM; Taylor EA; Wadsworth J; Turner P
    Eur J Clin Pharmacol; 1979 Mar; 15(2):91-6. PubMed ID: 436923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An investigation of "absolute plasma level effect relationships" and "absolute cardioselectivity" with respect to beta-adrenoceptor blockade.
    Kumana CR; Kaye CM; Leighton M; Marlin GE
    Eur J Clin Pharmacol; 1977 Aug; 12(1):7-13. PubMed ID: 332505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New approach to assessment of cardioselectivity of beta-blocking drugs.
    Kumana CR; Marlin GE; Kaye CM; Smith DM
    Br Med J; 1974 Nov; 4(5942):444-7. PubMed ID: 4425917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of environmental temperature and humidity on bronchial responses during assessment of selectivity of beta-adrenoceptor antagonists in man.
    Taylor EA; Trembath PW; Warrington SJ
    Br J Clin Pharmacol; 1981 Aug; 12(2):201-9. PubMed ID: 6118171
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of cardioselectivity and partial agonist activity in beta-adrenoceptor blockade comparing effects on heart rate and peak expiratory flow rate during exercise.
    Oh VM; Kaye CM; Warrington SJ; Taylor EA; Wadsworth J
    Br J Clin Pharmacol; 1978 Feb; 5(2):107-20. PubMed ID: 23136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiac and pulmonary effects of acebutolol.
    Kumana CR; Kaye CM; Leighton M; Turner P; Hamer J
    Lancet; 1975 Jul; 2(7925):89-93. PubMed ID: 49736
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man.
    Williams FM; Singh BN; Ambler PK; Dorrington R
    Clin Exp Pharmacol Physiol; 1976; 3(5):473-82. PubMed ID: 975632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels and beta-adrenoceptor blockade with acebutolol, practolol and propranolol in man.
    Cuthbert MF; Collins RF
    Br J Clin Pharmacol; 1975 Feb; 2(1):49-55. PubMed ID: 1234486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade.
    McDevitt DG; Brown HC; Carruthers SG; Shanks RG
    Clin Pharmacol Ther; 1977 May; 21(5):556-66. PubMed ID: 15753
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative assessment of bronchial beta-adrenoceptor blockade in man.
    Gribbin HR; Baldwin CJ; Tattersfield AE
    Br J Clin Pharmacol; 1979 Jun; 7(6):551-6. PubMed ID: 37867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of bronchial beta blockade after oral bevantolol.
    Mackay AD; Gribbin HR; Baldwin CJ; Tattersfield AE
    Clin Pharmacol Ther; 1981 Jan; 29(1):1-6. PubMed ID: 6109585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of cardioselective beta adrenoceptor blockade on specific airways resistance in normal subjects and in patients with bronchial asthma.
    Singh BN; Whitlock RM; Comber RH; Williams FH; Harris EA
    Clin Pharmacol Ther; 1976 May; 19(5 Pt 1):493-501. PubMed ID: 6179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Divergent effects of atenolol, practolol and propranolol on the peripheral metabolic changes induced by dynamic exercise in healthy men.
    Laustiola K; Uusitalo A; Koivula T; Sovijärvi A; Seppälä E; Nikkari T; Vapaatalo H
    Eur J Clin Pharmacol; 1983; 25(3):293-7. PubMed ID: 6628516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of practolol on exercise tolerance and cardiac haemodynamics and metabolism in patients with coronary artery disease.
    Dagenais GR; Moisan A; Marquis Y; Davies RO; Blouin S
    Cardiovasc Res; 1976 Jan; 10(1):25-36. PubMed ID: 1253193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic heart rate on exercise and the measurement of beta-adrenoceptor blockade.
    Carruthers SG; Shanks RG; McDevitt DG
    Br J Clin Pharmacol; 1976 Dec; 3(6):991-9. PubMed ID: 22216520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The beta-adrenoceptor blocking properties of the alpha-methyl analogues of propranolol and practolol in the anaesthetized dog.
    Levy B
    Br J Pharmacol; 1973 Nov; 49(3):514-26. PubMed ID: 4777711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart rate and blood pressure responses to intravenous boluses of isoprenaline in the presence of propranolol, practolol and atropine.
    Arnold JM; McDevitt DG
    Br J Clin Pharmacol; 1983 Aug; 16(2):175-84. PubMed ID: 6137231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective beta-1 receptor blockade with oral practolol in man. A dose-related phenomenon.
    Lertora JJ; Mark AL; Johannsen J; Wilson WR; Abboud FM
    J Clin Invest; 1975 Sep; 56(3):719-24. PubMed ID: 239966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Isoprenaline- and exercise- induced tachycardia in the assessment of beta-adrenoceptor blocking drugs; a comparison between tolamolol, practolol and propranolol.
    Adam KR; Pullman LG; Scholfield PC
    Br J Pharmacol; 1973 Nov; 49(3):560-3. PubMed ID: 4149697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of respiratory and cardiovascular effects of isoproterenol, propranolol, and practolol in asthmatic and normal subjects.
    Ryo UY; Townley RG
    J Allergy Clin Immunol; 1976 Jan; 57(1):12-24. PubMed ID: 1245680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.